NorthView Acquisition Corp financial data

Symbol
NVAC, NVACR, NVACW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
207 West 25 Th St, 9 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Dec 17, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13.4 % +2.53%
Debt-to-equity -113 % +10.1%
Return On Equity 19.6 %
Return On Assets -9.69 % -491%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.88M shares -4.65%
Common Stock, Shares, Outstanding 5.19M shares 0%
Common Stock, Value, Issued 519 USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.19M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 5.19M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -1.5M USD -3.15%
Nonoperating Income (Expense) 701K USD -81.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -800K USD -135%
Income Tax Expense (Benefit) 90.3K USD -23.5%
Net Income (Loss) Attributable to Parent -891K USD -163%
Earnings Per Share, Basic -0.17 USD/shares -231%
Earnings Per Share, Diluted -0.17 USD/shares -213%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 533 USD
Assets, Current 682K USD +346%
Assets 8.78M USD -18.7%
Accrued Liabilities, Current 727K USD
Liabilities, Current 5.17M USD +72.2%
Deferred Income Tax Liabilities, Net 13.7K USD -63%
Liabilities 5.82M USD +58.7%
Retained Earnings (Accumulated Deficit) -5.18M USD -48.6%
Stockholders' Equity Attributable to Parent -5.18M USD -48.6%
Liabilities and Equity 8.78M USD -18.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -281K USD +70.9%
Net Cash Provided by (Used in) Financing Activities -2.28M USD +98.8%
Net Cash Provided by (Used in) Investing Activities 2.56M USD -98.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 5.19M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 533 USD -96.9%
Deferred Tax Assets, Valuation Allowance 436K USD +87.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 423K USD +116%
Deferred Income Tax Expense (Benefit) -13.7K USD +61.6%
Deferred Tax Assets, Operating Loss Carryforwards 436K USD +87.6%
Preferred Stock, Shares Authorized 1M shares 0%
Deferred Tax Assets, Net of Valuation Allowance 13.7K USD -63%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%